Pycnogenol for Menopause: What the Evidence Shows
Updated August 2026
Along the Atlantic coast of southwest France, a hardy pine called Pinus pinaster grows in sandy soil and salt wind. Its thick outer bark is rich in protective compounds called procyanidins. Decades ago, researchers learned to extract those compounds into a consistent, standardized ingredient.
That consistency changed everything. Because every batch is nearly identical, scientists could run real placebo-controlled trials on it. This one bark extract now has more peri/menopause trial data than most botanicals on the shelf.
The extract is sold under the trademarked name Pycnogenol, and it deserves a clear-eyed look.
Pycnogenol is a standardized extract of French maritime pine bark (Pinus pinaster) that has improved overall menopausal symptom scores in three placebo-controlled clinical trials, working through antioxidant and circulation pathways rather than hormonal activity.
Key takeaways
- Pycnogenol is a branded, standardized pine bark extract rich in procyanidins. Standardization is why it has clinical trials at all.
- Three placebo-controlled trials, covering roughly 400 women at doses from 60 mg to 200 mg daily, found improvements in overall climacteric symptom scores, including vasomotor symptoms, sleep, and mood measures.
- It showed no changes to estrogen or other hormone levels in trials. Its mechanism appears to be antioxidant and blood vessel support.
- The trials are small to mid-sized, and it is one extract working one lane, not a full answer to the clustered pattern many women experience.
What Pycnogenol is
Pycnogenol is a trademarked extract of French maritime pine bark, developed and standardized by Horphag Research. It is standardized to a consistent level of procyanidins, the antioxidant compounds that give the bark its activity. Source: Rohdewald, pharmacology review (PMID 11996210)
That detail matters. Most herbal ingredients vary from batch to batch, which makes them hard to study. A standardized extract behaves the same way in every capsule, so researchers can test it, repeat the test, and compare results. This is why one pine bark extract has a peri/menopause evidence base while hundreds of generic botanicals do not.
What the clinical trials show
Three placebo-controlled trials have tested Pycnogenol in women moving through the transition. Together they make it one of the better-tested single botanicals for peri/menopause, and that is worth saying plainly.
The 2007 Taiwan trial. Researchers enrolled 200 perimenopausal women in a randomized, double-blind, placebo-controlled trial; 155 completed it. Women took 200 mg of Pycnogenol or placebo daily for six months. The Pycnogenol group improved across the symptoms on the Women's Health Questionnaire, a validated scale covering mood, sleep, vasomotor symptoms, and more. Antioxidant status rose and cholesterol profiles improved, with no side effects reported. Source: Yang et al., Acta Obstetricia et Gynecologica Scandinavica 2007 (PMID 17653885)
The 2013 Japanese low-dose trial. Kohama and Negami tested a much smaller dose: 60 mg daily for 12 weeks in 170 perimenopausal women aged 42 to 58, again randomized and placebo-controlled. Symptom scores on the Kupperman index improved versus placebo by week 4 and held at week 12. The clearest gains were in vasomotor symptoms and sleep. Notably, hormone levels including estradiol and FSH did not change. Source: Kohama & Negami, Journal of Reproductive Medicine 2013 (PMID 23447917)
The 2011 Italian study. A smaller controlled study in Panminerva Medica followed 70 women in the menopausal transition, 38 taking 100 mg of Pycnogenol daily for 8 weeks and 32 serving as controls. Most symptoms on a 34-item scale improved, including hot flashes, mood swings, and fatigue, and blood markers of oxidative stress dropped. Sleep scores did not significantly change in this one. Source: Errichi et al., Panminerva Medica 2011 (PMID 22108479)
The pattern across all three: broad symptom scores improve, vasomotor and mood measures improve most consistently, and tolerability is good.
The caveats, stated fairly
The evidence is real, and it has limits. Both things are true.
- The trials are small to mid-sized. A few hundred women total is respectable for a botanical and modest by pharmaceutical standards. Memorial Sloan Kettering notes that larger studies are still needed. Source: MSKCC, Pine Bark Extract monograph
- Manufacturer affiliation is common in this category. Some Pycnogenol research involves scientists connected to the ingredient's maker. The 2013 Japanese trial was run independently, which strengthens the picture, but more fully independent replication would help.
- It is one extract, not a category. The results apply to this standardized extract at studied doses. A generic pine bark extract on a discount shelf has not earned the same claims.
How it works, in plain language
Pycnogenol does not act like a hormone. The 2013 trial measured estradiol, FSH, and other hormones directly and found no changes, even as symptoms improved. Source: Kohama & Negami 2013 (PMID 23447917)
Instead, it works on the terrain around the hormones. Its procyanidins are strong antioxidants that mop up unstable molecules linked to cellular stress. It also supports the lining of your blood vessels, helping them relax and widen through nitric oxide. Source: MSKCC, Pine Bark Extract monograph
That circulation story may explain why vasomotor symptoms respond. A hot flash is partly a blood vessel event: vessels dilating suddenly at the wrong signal. An extract that steadies vessel behavior supports the system that misfires.
Traditional Chinese Medicine (TCM) reads the same picture as internal heat rising when the body loses its ability to cool and regulate itself. Different vocabulary, same observation.
How it compares with other single botanicals
Single botanicals each tend to work one lane. A quick comparison shows the shape of the evidence.
| Pycnogenol | Black cohosh | Ashwagandha | |
|---|---|---|---|
| What it is | Standardized French maritime pine bark extract | North American root extract | Ayurvedic adaptogen root |
| Main target | Overall symptom scores, vasomotor, sleep and mood measures | Vasomotor symptoms (hot flashes, night sweats) | Stress load, tension, sleep quality |
| Evidence character | Three placebo-controlled trials of one standardized extract, consistent direction | Many trials over decades, mixed results, extract quality varies widely | Growing trial base, mostly in stress and sleep, less peri/menopause-specific |
| Hormonal activity | None reported in trials | Debated; current evidence suggests non-estrogenic | None established |
For a deeper look at each, read our explainers on black cohosh and ashwagandha.
Who might consider Pycnogenol
Pycnogenol is a reasonable option to discuss with your doctor if hot flashes or circulation-linked symptoms sit at the center of your experience, and you want a non-hormonal single ingredient you can evaluate on its own.
A few cautions. It can slow platelet clumping, so talk with your doctor first if you take blood thinners such as warfarin. Skip it if you are allergic to pine. And buy the branded, standardized extract at studied doses (60 mg to 200 mg daily in trials), since that is what the evidence covers. Source: MSKCC, Pine Bark Extract monograph
Where The Shift fits
A single extract works one lane. That is its strength and its ceiling.
Most women are not dealing with one lane. In our 30-day consumer research study, the heaviest symptoms clustered together: brain fog, tension you can't unwind, irritability and anxiety, low energy, and sleep wakings. Vasomotor symptoms ranked last. Source: Project M study results
The Shift is Project M's daily herbal protocol for perimenopause, built on a 600-year-old Traditional Chinese Medicine formula. Rather than one compound working one pathway, it uses a hierarchy of herbs, led by Bupleurum (Chai Hu) and Peony (Bai Shao), to support the stress response, ease tension, and steady sleep and mood as a system.
The two approaches are not rivals. Some women pair a single-lane extract like Pycnogenol with a multi-herb formula, with their doctor informed of everything they take. Match the tool to the pattern you actually have.
A steadier system, not a stronger override.
Frequently asked questions
Does Pycnogenol help with menopause symptoms?
The published evidence suggests it can support overall comfort during the transition. Three placebo-controlled trials in roughly 400 peri/menopausal women found improved symptom scores versus placebo, with the most consistent gains in vasomotor, sleep, and mood measures. The trials were small to mid-sized, so the evidence is promising rather than definitive.
How much Pycnogenol should I take?
Studied doses ranged from 60 mg to 200 mg daily. The 2013 trial found benefits at just 60 mg per day over 12 weeks, while the 2007 trial used 200 mg daily for six months. Start with your doctor's guidance, especially if you take any medication.
Is Pycnogenol the same as regular pine bark extract?
No. Pycnogenol is a trademarked extract of French maritime pine bark, standardized to a set procyanidin content by Horphag Research. The clinical trials used this specific extract. Generic pine bark extracts vary in source, strength, and quality, so trial results do not automatically transfer.
Can I take Pycnogenol with other supplements?
Generally yes, and many women combine a single extract with a broader formula. Two cautions: it may increase bleeding risk alongside blood thinners, and stacking several products makes it harder to tell what is working. Introduce one change at a time and keep your doctor informed.
The Shift
Ancient Wisdom. Modern Balance.
One daily blend for the whole transition, rooted in centuries of wisdom and backed by modern science.
- 86% saw improvements within 30 days
- Hormone-free, no hidden junk
- 90 day risk free guarantee
Read next
- Black cohosh for menopause: what the research shows
- Ashwagandha for menopause: evidence and how to use it
- Adaptogens for perimenopause: a grounded guide
- Best menopause supplements: how to evaluate them
- Herbal supplements vs. HRT: how to think about both
Sources
- Yang HM, et al. A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women. Acta Obstet Gynecol Scand. 2007 (PMID 17653885)
- Kohama T, Negami M. Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women. J Reprod Med. 2013 (PMID 23447917)
- Errichi S, et al. Supplementation with Pycnogenol improves signs and symptoms of menopausal transition. Panminerva Med. 2011 (PMID 22108479)
- Memorial Sloan Kettering Cancer Center. Pine Bark Extract: Purported Benefits, Side Effects & More
- Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther. 2002 (PMID 11996210)
- Project M 30-day consumer research study results
